Carlos Luri-Rey

11PUBLICATIONS
66CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Instruments and techniquesTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 07, 2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

|Aug 25, 2026
CD137 agonists in mice suppress germinal center responses by increasing the immunosuppressive activity of follicular regulatory T-cells.

|Aug 06, 2026
Antibody-Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors.

|Apr 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Alvaro Teijeira, Saray Garasa, Maria C Ochoa

|Oct 02, 2023
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.

Ignacio Melero, Maria C Ochoa, Carmen Molina

|Sep 01, 2023
Druggable Targets in Cytokine Release Syndromes.

Carlos Luri-Rey, Iñaki Eguren-Santamaria, Ignacio Matos

Pageof 2

Frequent Collaborators

11 joint publications

Ignacio Melero

9 joint publications

Pedro Berraondo

7 joint publications

Alvaro Teijeira

7 joint publications

Carlos E de Andrea